Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

被引：0
作者：
E Elez
A Hendlisz
T Delaunoit
J Sastre
A Cervantes
R Varea
G Chao
J Wallin
J Tabernero
机构：
[1] Vall d’Hebron Institute of Oncology Barcelona,
[2] Spain and Universitat Autònoma de Barcelona,undefined
[3] Institut Jules Bordet,undefined
[4] Centres Hospitaliers Jolimont,undefined
[5] Hospital Universitario San Carlos,undefined
[6] Biomedical Research Institute INCLIVA,undefined
[7] University of Valencia,undefined
[8] Eli Lilly and Company,undefined
[9] Eli Lilly and Company,undefined
[10] Eli Lilly and Company,undefined
来源：
British Journal of Cancer | 2016年 / 114卷
关键词：
advanced colorectal cancer; modified FOLFOX6; necitumumab; KRAS; EGFR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：372 / 380
页数：8
相关论文
共 399 条
[31]  
Aparicio J(undefined)undefined undefined undefined undefined-undefined
[32]  
de Braud F(undefined)undefined undefined undefined undefined-undefined
[33]  
Donea S(undefined)undefined undefined undefined undefined-undefined
[34]  
Ludwig H(undefined)undefined undefined undefined undefined-undefined
[35]  
Schuch G(undefined)undefined undefined undefined undefined-undefined
[36]  
Stroh C(undefined)undefined undefined undefined undefined-undefined
[37]  
Loos AH(undefined)undefined undefined undefined undefined-undefined
[38]  
Zubel A(undefined)undefined undefined undefined undefined-undefined
[39]  
Koralewski P(undefined)undefined undefined undefined undefined-undefined
[40]  
Bokemeyer C(undefined)undefined undefined undefined undefined-undefined
12345678910